Recombinant LEPR (Mibavademab Biosimilar) antibody
The Human Monoclonal anti-LEPR (Mibavademab Biosimilar) antibody is suitable to detect LEPR (Mibavademab Biosimilar) in samples from Human. It has been validated for ELISA, FACS, BLI, Func and SPR.
Catalog No. ABIN7675786
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant LEPR (Mibavademab Biosimilar) antibody (ABIN7675786)
Target
LEPR (Mibavademab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This LEPR (Mibavademab Biosimilar) antibody is un-conjugated
Application
ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-LEPR / CD295 Reference Antibody (mibavademab)
-
Characteristics
- Anti-LEPR / CD295 Reference Antibody (mibavademab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG4 S228P
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- LEPR (Mibavademab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- P48357
Target
-
You are here:
